Connect with us

Hi, what are you looking for?

Investing

Events startup Pollen enters administration months after raising £124m

London-based events startup Pollen has entered administration after failing to find a buyer. The collapse of Pollen comes just months after it raised $150m (£124) in funding.

The company, which has received taxpayer funding via the government’s Future Fund, had been seeking a buyer for the whole business.

But according to an email sent by one of Pollen’s co-founders and seen by Sifted, parent company StreetTeam Software Limited is “appointing administrators to restructure after we were not able to sell the company in its entirety”.

The restructuring will see the company’s college travel business split off from the consumer-facing events business, Pollen.

The writing appeared to be on the wall for Pollen for many months. Sky News reported on Tuesday that the startup had been looking for a buyer for weeks after calling in Goldman Sachs to assist with a buyout.

Early on Wednesday, the Telegraph confirmed that Pollen was unable to find a buyer and had hired Kroll to “administer its restructuring”.

Pollen struggles

In April, Pollen raised £124m in Series C funding. Despite this, Pollen has been struggling to pay operators, employees and customer refunds for cancelled events.

Founded in 2014 by brothers Callum and Liam Negus-Fancey, Pollen works with music and events promoters to sell curated experiences. The company said it had been blighted by Covid-19 restrictions globally and the more recent economic downturn.

The cancellation of events has created ire among customers who have complained of being unable to get a refund.

UKTN was unable to reach Pollen for comment.

According to Crunchbase, Pollen has received a total of $238.5m (£197.3m) to date. Backers include the likes of Kindred, Northzone, Sienna Capital and Rishi Sunak’s Future Fund.

It’s not the only events platform that is having a rough time, with competitor Hopin reducing its employee headcount by 29% last month.

Read more:
Events startup Pollen enters administration months after raising £124m

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Economy

WASHINGTON D.C. — The United States is seeking to form a coalition of countries to drive negotiations on a global plastic pollution treaty, weeks...

Economy

By Diego Gabriel C. Robles  THE WORLD BANK (WB) upgraded its growth forecast for the Philippines for this year and 2023, citing an “accommodative”...

Economy

THE PHILIPPINE auto industry’s sales recovery will likely be derailed if a measure reimposing excise taxes on pickup trucks is signed into law, according...

Economy

THE BANGKO SENTRAL ng Pilipinas (BSP) may deliver a second off-cycle rate hike in early November when the US Federal Reserve is expected to...

Economy

THE ASIAN Development Bank (ADB) is planning to allocate at least $14 billion for a program aimed at easing a food crisis in the...

Investing

With the reversal of the 1.25% rise in National Insurance Contributions happening on the 6th of November, employers across the nation have an opportunity...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Investing

The minute that any question pops into your head, you can simply ask Google. No longer do we have to pour over books and...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.